MARGINAL ZONE LYMPHOMA OF OCULAR ADNEXAL
Clinical trials for MARGINAL ZONE LYMPHOMA OF OCULAR ADNEXAL explained in plain language.
Never miss a new study
Get alerted when new MARGINAL ZONE LYMPHOMA OF OCULAR ADNEXAL trials appear
Sign up with your email to follow new studies for MARGINAL ZONE LYMPHOMA OF OCULAR ADNEXAL, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
Antibiotics tested as first treatment for rare eye cancer
Disease control OngoingThis trial is testing if a long course of the antibiotic doxycycline can control a rare type of eye lymphoma by treating a possible bacterial infection linked to the cancer. It is for adults newly diagnosed with early-stage lymphoma only in the eye area who have not had recent an…
Matched conditions: MARGINAL ZONE LYMPHOMA OF OCULAR ADNEXAL
Phase: PHASE2 • Sponsor: International Extranodal Lymphoma Study Group (IELSG) • Aim: Disease control
Last updated Mar 27, 2026 12:40 UTC
-
New combo therapy aims to zap eye cancer with fewer side effects
Disease control OngoingThis study is testing if a new drug, orelabrutinib, works better and is safer when combined with either very low-dose radiation or another drug called rituximab for a rare, slow-growing lymphoma around the eye. It involves 39 adults with early-stage disease who haven't had prior …
Matched conditions: MARGINAL ZONE LYMPHOMA OF OCULAR ADNEXAL
Phase: PHASE2 • Sponsor: Second Affiliated Hospital, School of Medicine, Zhejiang University • Aim: Disease control
Last updated Mar 05, 2026 13:59 UTC